Skip to main content
SpringerLink
Log in

Risk factors contributing to the development of carboplatin-related delayed hypersensitivity reactions in Japanese patients with gynecologic cancers

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The rate of hypersensitivity reactions in patients receiving carboplatin (CBDCA) has been reported to increase after multiple doses of the agent. However, risk factors for these onsets have not been well described. In this study, we investigated the contribution of the reported risk factors to the onset of CBDCA-related delayed hypersensitivity reactions.

Methods

We reviewed the records of gynecologic cancer patients receiving CBDCA of more than 7 cycles in Mie University Hospital from March 2006 to July 2009. The patients were divided into two groups on the basis of whether hypersensitivity reactions developed (13 patients) or not (43 patients). Thereafter, the potential influences of the patients’ characteristics on the development of CBDCA-related delayed hypersensitivity reactions were explored using logistic regression analyses.

Results

The median CBDCA-free interval (10 months) in patients with hypersensitivity reactions was significantly higher than that (3 months) in patients without hypersensitivity reactions. Logistic regression analyses revealed a CBDCA-free interval >13 months (odds ratio 22.2, 95% confidence interval 2.57–192, p < 0.01) and a maximum dose of CBDCA > 650 mg (odds ratio 9.52, 95% confidence interval 1.04–93.9; p < 0.05) were significantly correlated with the incidence of CBDCA-related delayed hypersensitivity reactions.

Conclusions

Careful attention should be paid to the onset of delayed hypersensitivity reactions for recurrent gynecologic cancer patients receiving CBDCA > 650 mg after an interval of more than 13 months from the previous CBDCA administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Markman M, Kennedy A, Webster K, Elson P, Peterson G, Kulp B, Belinson J (1999) Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol 17:1141–1145

    CAS  PubMed  Google Scholar 

  2. Schwartz JR, Bandera C, Bradley A, Brard L, Legare R, Granai CO, Dizon DS (2007) Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants’ Hospital. Gynecol Oncol 105:81–83

    Article  CAS  PubMed  Google Scholar 

  3. Navo M, Kunthur A, Badell ML, Coffer LW 2nd, Markman M, Brown J, Smith JA (2006) Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients. Gynecol Oncol 103:608–613

    Article  CAS  PubMed  Google Scholar 

  4. Koshiba H, Hosokawa K, Kubo A, Miyagi Y, Oda T, Miyagi Y, Watanabe A, Honjo H (2009) Incidence of Carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies. Int J Gynecol Cancer 19:460–465

    Article  CAS  PubMed  Google Scholar 

  5. Weidmann B, Mülleneisen N, Bojko P, Niederle N (1994) Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management. Cancer 73:2218–2222

    Article  CAS  PubMed  Google Scholar 

  6. Weiss RB (1992) Hypersensitivity reactions. Semin Oncol 19:458–477

    CAS  PubMed  Google Scholar 

  7. Shepherd GM (2003) Hypersensitivity reactions to chemotherapeutic drugs. Clin Rev Allergy Immunol 24:253–262

    Article  CAS  PubMed  Google Scholar 

  8. Sliesoraitis S, Chikhale PJ (2005) Carboplatin hypersensitivity. Int J Gynecol Cancer 15:13–18

    Article  CAS  PubMed  Google Scholar 

  9. Zanotti KM, Rybicki LA, Kennedy AW, Belinson JL, Webster KD, Kulp B, Peterson G, Markman M (2001) Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 19:3126–3129

    CAS  PubMed  Google Scholar 

  10. Cromwell O, Pepys J, Parish WE, Hughes EG (1979) Specific IgE antibodies to platinum salts in sensitized workers. Clin Allergy 9:109–117

    Article  CAS  PubMed  Google Scholar 

  11. O’Cearbhaill R, Zhou Q, Iasonos A, Hensley ML, Tew WP, Aghajanian C, Spriggs DR, Lichtman SM, Sabbatini PJ (2010) The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment. Gynecol Oncol (in press)

  12. Syrigou EI, Karapanagiotou EM, Alamara CV, Boura PG, Saif MW, Syrigos KN (2009) Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol. Clin Colorectal Cancer 8:106–109

    Article  CAS  Google Scholar 

  13. Watanabe Y, Nakai H, Ueda H, Nozaki K, Hoshiai H (2005) Carboplatin hypersensitivity induced by low-dose paclitaxel/carboplatin in multiple platinum-treated patients with recurrent ovarian cancer. Int J Gynecol Cancer 15:224–227

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

No author has any conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pharmacy, Mie University Hospital, Faculty of Medicine, Mie University, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan

    Hiroko Sugimoto, Takuya Iwamoto, Yukiko Murashima & Masahiro Okuda

  2. Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Tsu, Mie, 514-8507, Japan

    Tsutomu Tabata & Norimasa Sagawa

Authors
  1. Hiroko Sugimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takuya Iwamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yukiko Murashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tsutomu Tabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Norimasa Sagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masahiro Okuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masahiro Okuda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugimoto, H., Iwamoto, T., Murashima, Y. et al. Risk factors contributing to the development of carboplatin-related delayed hypersensitivity reactions in Japanese patients with gynecologic cancers. Cancer Chemother Pharmacol 67, 415–419 (2011). https://doi.org/10.1007/s00280-010-1338-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-010-1338-5

Keywords

Search

Navigation